A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)
Trial details
- Registry ID
- NCT05343455
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)NCT05343455 | Journey Medical Corporation | Phase 3 | Completed | 2023-06-30Actual |
| A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.NCT05296629 | Journey Medical Corporation | Phase 3 | Completed | 2023-06-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |